Israel Chemicals (NYSE:ICL) Upgraded to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Israel Chemicals (NYSE:ICL) from a sell rating to a hold rating in a report published on Thursday morning, Zacks.com reports.

According to Zacks, “Israel Chemicals Ltd. is a manufacturer of specialty fertilizers and specialty phosphates, flame retardants and water treatment solutions. It operates primarily in three markets: agriculture, food and engineered materials. The Company’s products include bromine specialty chemicals, potash, phosphate fertilizers, and specialty performance and industrial products. It markets its products primarily in Israel, Europe, and the Americas. Israel Chemicals Ltd. is headquartered in Tel Aviv, Israel. “

Separately, Barclays started coverage on Israel Chemicals in a report on Thursday, January 16th. They set an equal weight rating for the company.

Israel Chemicals stock traded down $0.01 during mid-day trading on Thursday, hitting $4.11. 133,213 shares of the company’s stock traded hands, compared to its average volume of 183,991. The firm has a 50 day simple moving average of $4.44 and a two-hundred day simple moving average of $4.67. Israel Chemicals has a fifty-two week low of $3.85 and a fifty-two week high of $5.73. The stock has a market cap of $5.52 billion, a price-to-earnings ratio of 10.54, a P/E/G ratio of 1.04 and a beta of 0.95. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.51 and a quick ratio of 0.84.

Israel Chemicals (NYSE:ICL) last announced its quarterly earnings results on Thursday, February 13th. The basic materials company reported $0.04 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.04. Israel Chemicals had a return on equity of 13.82% and a net margin of 9.13%. The business had revenue of $1.11 billion during the quarter. On average, research analysts anticipate that Israel Chemicals will post 0.39 earnings per share for the current fiscal year.

A number of institutional investors have recently made changes to their positions in ICL. First Trust Advisors LP acquired a new stake in shares of Israel Chemicals during the first quarter worth $73,000. Morgan Stanley lifted its holdings in shares of Israel Chemicals by 20.4% during the second quarter. Morgan Stanley now owns 92,612 shares of the basic materials company’s stock worth $481,000 after buying an additional 15,701 shares in the last quarter. Signaturefd LLC lifted its holdings in shares of Israel Chemicals by 63.5% during the third quarter. Signaturefd LLC now owns 21,451 shares of the basic materials company’s stock worth $107,000 after buying an additional 8,332 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Israel Chemicals by 9.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 186,186 shares of the basic materials company’s stock worth $925,000 after buying an additional 15,759 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its holdings in shares of Israel Chemicals by 89.3% during the third quarter. Quadrant Capital Group LLC now owns 64,074 shares of the basic materials company’s stock worth $318,000 after buying an additional 30,227 shares in the last quarter. 5.62% of the stock is owned by institutional investors and hedge funds.

About Israel Chemicals

Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.

Featured Story: S&P 500 Index

Get a free copy of the Zacks research report on Israel Chemicals (ICL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.